BridgeMD
New treatment option for Multiple Sclerosis
Official title Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis
ClinicalTrials.gov ID: NCT06546033
What this study is testing
- What it's testing
- When the literature was reviewed, there is no study in which the effects of intermittent fasting and Mediterranean diet on quality of life, sleep, circadian rhythm and appetite hormones leptin and ghrelin levels in MS patients were evaluated and the two diet types were comparatively examined in terms of all these parameters.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- To apply to the neurology outpatient clinic, to be a female between the ages of 18-65 who has been diagnosed with MS by a physician
- Not being in the attack period
- Not being in menopause Not being diagnosed with any autoimmune system disease other than -MS that may adversely affect the study,
- Not following the Mediterranean diet and intermittent fasting programmes in the last three months,
- Not being diagnosed with an eating behaviour disorder,
You likely can't join if
- Having a diagnosis of autoimmune system disease that may adversely affect working outside of -MS,
- To be in the attack period-Being under 18 years of age and over 65 years of age
- Being in menopause-Mediterranean diet and intermittent fasting feeding programmes within the last three months,
- Diet therapy that has an effect on the autoimmune system within the last three months,
- Being diagnosed with eating behaviour disorder,
- Having any communication problems,- Not signing the informed consent form,
See the full eligibility criteria
- To apply to the neurology outpatient clinic, to be a female between the ages of 18-65 who has been diagnosed with MS by a physician
- Not being in the attack period
- Not being in menopause Not being diagnosed with any autoimmune system disease other than -MS that may adversely affect the study,
- Not following the Mediterranean diet and intermittent fasting programmes in the last three months,
- Not being diagnosed with an eating behaviour disorder,
- Not having any communication problems,
- Signing the informed consent form,
- Brain MRI within the last three months,
- Not to be pregnant and lactating
- No physical disability No history of cancer
- Body Mass Index between 18,5 kg/m2- 29,9 kg/m2,
- Not losing 5% and/or more body weight in the last month
- Having a diagnosis of autoimmune system disease that may adversely affect working outside of -MS,
- To be in the attack period-Being under 18 years of age and over 65 years of age
- Being in menopause-Mediterranean diet and intermittent fasting feeding programmes within the last three months,
- Diet therapy that has an effect on the autoimmune system within the last three months,
- Being diagnosed with eating behaviour disorder,
- Having any communication problems,- Not signing the informed consent form,
- Failure to adapt to the work during the working period, to be in a situation/behaviour that may adversely affect the work,
- To have applied any nutritional intervention during the last three months prior to the study,
- Taking supplements such as selenium, zinc, iron, vitamin D and/or B12, which may affect the course of the study,
- To have received cancer treatment and / or to be receiving cancer treatment,
- Other neurological diseases (e.g. Parkinson's, epilepsy, Alzheimer's),
- Diagnosed with a disease lasting more than 4 months in the last 12 months and other specialised dietary / compositionally different dietary patterns (e.g. high protein, ketogenic, low energy content \< 1000 kcal/day),
- Body Mass Index \ 30 kg/m2
- Losing 5% and/or more body weight in the last month,
- Having a physical disability
The study team makes the final eligibility decision.
Where it's taking place
- Niğde, Bor, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Niğde, Bor, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.